Zhiyong Yang Selected Research

Hypoxia (Hypoxemia)

1/2023	Selenium-Containing Type-I Organic Photosensitizers with Dual Reactive Oxygen Species of Superoxide and Hydroxyl Radicals as Switch-Hitter for Photodynamic Therapy.
1/2022	Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor.
2/2018	Gastrodin protects myocardial cells against hypoxia/reoxygenation injury in neonatal rats by inhibiting cell autophagy through the activation of mTOR signals in PI3K-Akt pathway.
10/2007	Preparation and preservation of hypoxia UW solution.
1/2006	Effect of HIF-1alpha on VEGF-C induced lymphangiogenesis and lymph nodes metastases of pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyong Yang Research Topics

Disease

32	Neoplasms (Cancer) 01/2024 - 04/2006
9	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022 - 01/2006
9	Glaucoma 01/2021 - 12/2007
7	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2006
5	Hypertension (High Blood Pressure) 01/2024 - 05/2006
5	Pancreatitis 09/2023 - 01/2003
5	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 07/2011
5	Hypoxia (Hypoxemia) 01/2023 - 01/2006
5	Inflammation (Inflammations) 01/2018 - 11/2009
5	Infections 01/2018 - 03/2014
5	Osteoarthritis 02/2010 - 03/2005
4	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 01/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2017
4	Clostridium Infections 10/2020 - 09/2014
4	Fibrosis (Cirrhosis) 01/2018 - 09/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022 - 01/2019
3	Intestinal Diseases (Diseases, Intestinal) 10/2020 - 07/2015
3	Hypersensitivity (Allergy) 01/2020 - 06/2014
3	Optic Nerve Injuries 06/2017 - 12/2007
3	Parkinson Disease (Parkinson's Disease) 01/2016 - 01/2013
2	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 08/2022
2	Myocardial Infarction 01/2023 - 01/2022
2	Macular Degeneration (Age-Related Maculopathy) 01/2023 - 01/2022
2	Disease Progression 01/2023 - 08/2015
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 08/2018
2	Blindness (Hysterical Blindness) 01/2023 - 01/2022
2	Stroke (Strokes) 01/2023 - 01/2022
2	Glioma (Gliomas) 06/2022 - 12/2014
2	Hematoma 11/2021 - 01/2019
2	Human Influenza (Influenza) 07/2021 - 11/2018
2	Breast Neoplasms (Breast Cancer) 06/2021 - 09/2015
2	Heart Failure 05/2021 - 12/2020
2	Pain (Aches) 01/2021 - 02/2010
2	Carcinogenesis 08/2020 - 01/2018
2	Pathologic Processes 01/2018 - 01/2013
2	Asthma (Bronchial Asthma) 01/2018 - 06/2014
2	Brain Injuries (Brain Injury) 11/2017 - 12/2014
2	Colitis 10/2016 - 02/2015
2	Ganglion Cysts (Ganglion) 01/2015 - 01/2013
2	Temporal Lobe Epilepsy 03/2014 - 06/2012
2	Rhabdomyosarcoma 01/2014 - 10/2013
2	Alzheimer Disease (Alzheimer's Disease) 10/2013 - 12/2012
2	Drug Resistant Epilepsy 06/2012 - 10/2011
2	Epilepsy (Aura) 06/2012 - 10/2011
2	Essential Hypertension 03/2009 - 03/2007
1	Hemorrhage 05/2024

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
8	AntibodiesIBA 09/2023 - 05/2012
6	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2018 - 09/2014
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2007
4	Immunoglobulin E (IgE)IBA 01/2020 - 05/2012
3	Single-Domain AntibodiesIBA 01/2024 - 09/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2022
3	Oxygen (Dioxygen)IBA 01/2023 - 10/2007
3	Gemcitabine FDA Link 02/2020 - 01/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2016 - 02/2015
3	Retinaldehyde (Retinal)IBA 01/2015 - 12/2007
3	Insulin-Like PeptidesIBA 01/2014 - 02/2013
3	Insulin-Like Growth Factor Binding Protein 6IBA 01/2014 - 02/2013
3	Aggrecans (Aggrecan)IBA 10/2009 - 03/2005
3	Arginine (L-Arginine)FDA Link 03/2009 - 05/2006
2	Protons (Proton)IBA 05/2024 - 07/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2024 - 01/2023
2	Photosensitizing Agents (Photosensitizers)IBA 01/2024 - 01/2023
2	Neutralizing AntibodiesIBA 09/2023 - 01/2015
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2023 - 04/2023
2	LipidsIBA 01/2023 - 01/2020
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 07/2014
2	AntitoxinsIBA 10/2020 - 02/2015
2	PolymersIBA 08/2020 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2007
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 02/2015
2	Neuroprotective AgentsIBA 11/2017 - 10/2013
2	Phosphotransferases (Kinase)IBA 06/2017 - 01/2014
2	Collagen Type I (Type I Collagen)IBA 01/2017 - 09/2014
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2016 - 01/2013
2	Small Interfering RNA (siRNA)IBA 09/2014 - 01/2011
2	Insulin-Like Growth Factor Binding ProteinsIBA 10/2013 - 02/2013
2	Insulin-Like Growth Factor II (Somatomedin A)IBA 10/2013 - 02/2013
2	LigandsIBA 02/2013 - 06/2012
2	Pilocarpine (Ocusert)FDA LinkGeneric 06/2012 - 10/2011
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2009 - 03/2007
2	3' Untranslated Regions (3' UTR)IBA 03/2009 - 03/2007
2	Vascular Endothelial Growth Factor CIBA 02/2007 - 01/2006

Therapy/Procedure

11	Brachytherapy 08/2022 - 08/2010
9	Therapeutics 01/2023 - 01/2011
5	Radiotherapy 05/2024 - 11/2021
5	Proton Therapy 05/2024 - 01/2019
5	Drug Therapy (Chemotherapy) 01/2024 - 08/2014
3	Immunotherapy 01/2024 - 10/2020
3	Photochemotherapy (Photodynamic Therapy) 01/2024 - 06/2016
3	Length of Stay 09/2023 - 03/2014
3	Surgical Navigation Systems 12/2022 - 08/2019
3	Catheters 11/2021 - 10/2015
3	Transplantation 01/2016 - 01/2013
2	Hepatectomy 04/2023 - 04/2023
2	Pancreaticoduodenectomy 01/2023 - 08/2018
2	Pancreatectomy 01/2006 - 01/2006